Discover open access scientific publications

Search, annotate, share and cite publications

Publications by M. Balducci

Chemotherapy Plus Concomitant Low-Dose Fractionated Radiotherapy as Second-Line Treatment for Recurrent or Progressive Glioblastoma After Temozolomide-Based Chemoradiation: A Pilot Study.

Journal of Clinical Oncology

English

25(OH) Vitamin D Serum Levels Associate With Patient Characteristics and Outcome in Hodgkin Lymphoma

Hematological Oncology

English

Related publications

Apatinib Plus Temozolomide for Recurrent Glioblastoma: An Uncontrolled, Open-Label Study

OncoTargets and Therapy

Oncology

Pharmacology

2019

English

Weekly Paclitaxel as Second-Line Chemotherapy for Advanced or Recurrent Gastric Cancer

English

Single Dose Bevacizumab as Treatment for Symptomatic, Corticosteroid-Refractory Pseudoprogression After Chemoradiation Therapy for Newly Diagnosed Glioblastoma: A Case Report

Integrative Cancer Science and Therapeutics

2015

English

Survival Benefit of Glioblastoma Patients After FDA Approval of Temozolomide Concomitant With Radiation and Bevacizumab: A Population-Based Study

Oncotarget

Oncology

2017

English

Hyper-Fractionated Radiotherapy for Soft Tissue Sarcoma: Results of the Second Study of Hyper-Fractionated Radiotherapy

English

Anti-Pd-1 Therapy Plus Chemotherapy and/or Bevacizumab as Second Line or Later Treatment for Patients With Advanced Non-Small Cell Lung Cancer

Journal of Cancer

Oncology

2020

English

Necrotizing Fasciitis: Low-Dose Radiotherapy as a Potential Adjunct Treatment

English

Predictors of Survival After Second Surgery for Recurrent Glioblastoma Tumours

Canadian Journal of Neurological Sciences

Medicine

Neurology

2015

English

Elective Lymph Node Irradiation Late Course Accelerated Hyper-Fractionated Radiotherapy Plus Concurrent Cisplatin-Based Chemotherapy for Esophageal Squamous Cell Carcinoma: A Phase II Study

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by M. Balducci

Chemotherapy Plus Concomitant Low-Dose Fractionated Radiotherapy as Second-Line Treatment for Recurrent or Progressive Glioblastoma After Temozolomide-Based Chemoradiation: A Pilot Study.

25(OH) Vitamin D Serum Levels Associate With Patient Characteristics and Outcome in Hodgkin Lymphoma

Related publications

Apatinib Plus Temozolomide for Recurrent Glioblastoma: An Uncontrolled, Open-Label Study

Weekly Paclitaxel as Second-Line Chemotherapy for Advanced or Recurrent Gastric Cancer

Single Dose Bevacizumab as Treatment for Symptomatic, Corticosteroid-Refractory Pseudoprogression After Chemoradiation Therapy for Newly Diagnosed Glioblastoma: A Case Report

Survival Benefit of Glioblastoma Patients After FDA Approval of Temozolomide Concomitant With Radiation and Bevacizumab: A Population-Based Study

Hyper-Fractionated Radiotherapy for Soft Tissue Sarcoma: Results of the Second Study of Hyper-Fractionated Radiotherapy

Anti-Pd-1 Therapy Plus Chemotherapy and/or Bevacizumab as Second Line or Later Treatment for Patients With Advanced Non-Small Cell Lung Cancer

Necrotizing Fasciitis: Low-Dose Radiotherapy as a Potential Adjunct Treatment

Predictors of Survival After Second Surgery for Recurrent Glioblastoma Tumours

Elective Lymph Node Irradiation Late Course Accelerated Hyper-Fractionated Radiotherapy Plus Concurrent Cisplatin-Based Chemotherapy for Esophageal Squamous Cell Carcinoma: A Phase II Study